Related references
Note: Only part of the references are listed.WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
Heba M. Hesham et al.
MEDICINAL RESEARCH REVIEWS (2018)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding et al.
SCIENTIFIC REPORTS (2018)
HDAC1 Substrate Profiling Using Proteomics-Based Substrate Trapping
Dhanusha A. Nalawansha et al.
ACS CHEMICAL BIOLOGY (2018)
LSD1 Substrate Binding and Gene Expression Are Affected by HDAC1-Mediated Deacetylation
Dhanusha A. Nalawansha et al.
ACS CHEMICAL BIOLOGY (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
Christos Damaskos et al.
ANTICANCER RESEARCH (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
HDAC Inhibitor-Induced Mitotic Arrest Is Mediated by Eg5/KIF11 Acetylation
Dhanusha A. Nalawansha et al.
CELL CHEMICAL BIOLOGY (2017)
Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
Weiqiang Zhou et al.
SCIENTIFIC REPORTS (2016)
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen- resistant breast cancer models, by reversing Bcl-2 overexpression
Paromita Raha et al.
BREAST CANCER RESEARCH (2015)
The potential of histone deacetylase inhibitors in breast cancer therapy
Namita Chatterjee et al.
BREAST CANCER MANAGEMENT (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mutagenesis Studies of the 14 Å Internal Cavity of Histone Deacetylase 1: Insights toward the Acetate-Escape Hypothesis and Selective Inhibitor Design
Magdalene K. Wambua et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The growing landscape of lysine acetylation links metabolism and cell signalling
Chunaram Choudhary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
Berit Maria Mueller et al.
BMC CANCER (2013)
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
Chandra R. Tate et al.
BREAST CANCER RESEARCH (2012)
MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays
Mehdi Nikkhah et al.
BIOMATERIALS (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Methyl-Binding Domain Protein 2-Dependent Proliferation and Survival of Breast Cancer Cells
Omar Y. Mian et al.
MOLECULAR CANCER RESEARCH (2011)
Epigenetic Regulation of Mesenchymal Stem Cells: A Focus on Osteogenic and Adipogenic Differentiation
Chad M. Teven et al.
STEM CELLS INTERNATIONAL (2011)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
Optimization of biaryl selective HDAC1&2 inhibitors (SHI-1&COLRATIO;2)
David J. Witter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Residues in the 11 A channel of histone deacetylase 1 promote catalytic activity: Implications for designing isoform-selective histone deacetylase inhibitors
Sujith V. W. Weerasinghe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Nuclear receptors and breast cancer
Suzanne D. Conzen
MOLECULAR ENDOCRINOLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate
Takayoshi Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer
H Zhang et al.
CLINICAL CANCER RESEARCH (2006)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Histone deacetylase-1 and-3 protein expression in human breast cancer:: a tissue microarray analysis
CA Krusche et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α
H Kawai et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Histone deacetylase as a therapeutic target
OH Krämer et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2001)
Share Paper
